|
|
||||||||
ORIGINAL RESEARCH |
From the Departments of Obstetrics and Gynecology and Pulmonary Medicine, University of Washington, Seattle, Washington.
Address reprint requests to: Thomas R. Easterling, MD, University of Washington, Box 356460, 1959 Pacific Street N.E., Seattle, WA 98105, E-mail: easter{at}u.washington.edu
Objective: To describe the clinical course of pregnancies complicated by pulmonary hypertension and treated with the pulmonary vasodilators nifedipine and prostacyclin.
Methods: Four pregnant women with pulmonary hypertension were treated with pulmonary vasodilators. Therapy with oral nifedipine and intravenous prostacyclin was guided by right pulmonary artery catheterization and Doppler measurements of cardiac output.
Results: Three of four women responded to vasodilator therapy and successfully completed their pregnancies. Two who conceived at least 1 year after successful treatment and normalized right ventricle function carried three uncomplicated pregnancies. The woman who did not respond died. Delay in diagnosis contributed to her outcome. Noninvasive measurement of cardiac output helped diagnosis of right ventricular failure and offered reassurance in women who remained compensated. Postpartum decompensation in one woman was characterized by a negative Starling response as central venous pressure increased from 4 to 11 mmHg. She responded positively to diuresis.
Conclusion: Early diagnosis of pulmonary hypertension is critical. Volume overload postpartum might significantly contribute to decompensation. We recommend a year of successful therapy after a response to vasodilator therapy and near-normal right ventricular function before pregnancy is considered. In complicated pregnancies, women must balance the best estimate of risk with the value they put on pregnancy.
This article has been cited by other articles:
![]() |
S. Huang and E. R. H. DeSantis Treatment of pulmonary arterial hypertension in pregnancy Am. J. Health Syst. Pharm., September 15, 2007; 64(18): 1922 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bendayan, M. Hod, G. Oron, A. Sagie, L. Eidelman, D. Shitrit, and M. R. Kramer Pregnancy Outcome in Patients With Pulmonary Arterial Hypertension Receiving Prostacyclin Therapy Obstet. Gynecol., November 1, 2005; 106(5): 1206 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Elliot, P. Stewart, V. J. Webster, G. H. Mills, S. P. Hutchinson, E. S. Howarth, F. A. Bu'Lock, R. A. Lawson, I. J. Armstrong, and D. G. Kiely The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension Eur. Respir. J., July 1, 2005; 26(1): 168 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ray, G. J. Murphy, and L. E. Shutt Recognition and management of maternal cardiac disease in pregnancy Br. J. Anaesth., September 1, 2004; 93(3): 428 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Bildirici and J B. Shumway Intravenous and Inhaled Epoprostenol for Primary Pulmonary Hypertension During Pregnancy and Delivery Obstet. Gynecol., May 1, 2004; 103(5): 1102 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Lam, R. E. Stafford, J. Thorp, K. J. Moise Jr, and B. A. Cairns Inhaled Nitric Oxide for Primary Pulmonary Hypertension in Pregnancy Obstet. Gynecol., November 1, 2001; 98(5): 895 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Decoene, K. Bourzoufi, D. Moreau, F. Narducci, F. Crepin, and R. Krivosic-Horber Use of inhaled nitric oxide for emergency Cesarean section in a woman with unexpected primary pulmonary hypertension : [L'inhalation d'oxyde nitrique pour la cesarienne d'urgence associee a une hypertension pulmonaire primitive inattendue] Can J Anesth, June 1, 2001; 48(6): 584 - 587. [Abstract] [Full Text] |
||||
![]() |
R. Stewart, D. Tuazon, G. Olson, and A. G. Duarte Pregnancy and Primary Pulmonary Hypertension : Successful Outcome With Epoprostenol Therapy Chest, March 1, 2001; 119(3): 973 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.M Weiss and O.M Hess Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives Eur. Heart J., January 2, 2000; 21(2): 104 - 115. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |